EICHOR
● Completed
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Condition: Type 2 Diabetes · Obesity · Overweight · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have obesity or overweight (J1I-MC-GZBK master protocol) including a subset of participants who have obstructive sleep apnea (OSA) (J1I-MC-GSA2). The study will last about 89 weeks and will include up to 24 visits.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (98)
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | — |
| Cullman Clinical Trials | Cullman, Alabama, United States | — |
| Preferred Research Partners | Little Rock, Arkansas, United States | — |
| Core Healthcare Group | Cerritos, California, United States | — |
| Velocity Clinical Research, Westlake | Los Angeles, California, United States | — |
| Valley Clinical Trials, Inc. | Northridge, California, United States | — |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | — |
| Chase Medical Research, LLC | Waterbury, Connecticut, United States | — |
| Excel Medical Clinical Trials | Boca Raton, Florida, United States | — |
| Teradan Clinical Trials, LLC | Brandon, Florida, United States | — |
| Fleming Island Center for Clinical Research | Fleming Island, Florida, United States | — |
| Therafirst Medical Center | Fort Lauderdale, Florida, United States | — |
+ 86 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.